Summary
Cell therapy, a new therapeutic approach that uses a patient's own immune cells to attack tumors, has emerged as one of the most promising breakthroughs in cancer treatment. NK cells are the body's first line of defense against infections and diseases with an innate ability to rapidly seek and destroy abnormal cells.
According to APO Research, The global Natural Killer Cell Therapy market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Natural Killer Cell Therapy is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Asia-Pacific market for Natural Killer Cell Therapy is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The China market for Natural Killer Cell Therapy is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
Europe market for Natural Killer Cell Therapy is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.
The major global companies of Natural Killer Cell Therapy include Nektar Therapeutics, Innate Pharma SA, Affimed, Chipscreen Biosciences, Glycostem Therapeutics, Fate Therapeutics, Dragonfly Therapeutics, Kiadis Pharma and Nkarta Therapeutics, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
Report Includes
This report presents an overview of global market for Natural Killer Cell Therapy, market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Natural Killer Cell Therapy, also provides the revenue of main regions and countries. Of the upcoming market potential for Natural Killer Cell Therapy, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Natural Killer Cell Therapy revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Natural Killer Cell Therapy market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Natural Killer Cell Therapy revenue, projected growth trends, production technology, application and end-user industry.
Natural Killer Cell Therapy segment by Company
Nektar Therapeutics
Innate Pharma SA
Affimed
Chipscreen Biosciences
Glycostem Therapeutics
Fate Therapeutics
Dragonfly Therapeutics
Kiadis Pharma
Nkarta Therapeutics
NantKwest
Natural Killer Cell Therapy segment by Type
NK Cell Therapies
NK Cell Directed Antibodies
Natural Killer Cell Therapy segment by Application
Cancer
Gastrointestinal Diseases
Others
Natural Killer Cell Therapy segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key players, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Natural Killer Cell Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Natural Killer Cell Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Natural Killer Cell Therapy.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Revenue of Natural Killer Cell Therapy in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 4: Detailed analysis of Natural Killer Cell Therapy company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Natural Killer Cell Therapy revenue, gross margin, and recent development, etc.
Chapter 8: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 9: Europe by type, by application and by country, revenue for each segment.
Chapter 10: China type, by application, revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.
Chapter 12: Middle East, Africa, and Latin America type, by application and by country, revenue for each segment.
Chapter 13: The main concluding insights of the report.
1 Market Overview
1.1 Product Definition
1.2 Natural Killer Cell Therapy Market by Type
1.2.1 Global Natural Killer Cell Therapy Market Size by Type, 2019 VS 2023 VS 2030
1.2.2 NK Cell Therapies
1.2.3 NK Cell Directed Antibodies
1.3 Natural Killer Cell Therapy Market by Application
1.3.1 Global Natural Killer Cell Therapy Market Size by Application, 2019 VS 2023 VS 2030
1.3.2 Cancer
1.3.3 Gastrointestinal Diseases
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Natural Killer Cell Therapy Market Dynamics
2.1 Natural Killer Cell Therapy Industry Trends
2.2 Natural Killer Cell Therapy Industry Drivers
2.3 Natural Killer Cell Therapy Industry Opportunities and Challenges
2.4 Natural Killer Cell Therapy Industry Restraints
3 Global Growth Perspective
3.1 Global Natural Killer Cell Therapy Market Perspective (2019-2030)
3.2 Global Natural Killer Cell Therapy Growth Trends by Region
3.2.1 Global Natural Killer Cell Therapy Market Size by Region: 2019 VS 2023 VS 2030
3.2.2 Global Natural Killer Cell Therapy Market Size by Region (2019-2024)
3.2.3 Global Natural Killer Cell Therapy Market Size by Region (2025-2030)
4 Competitive Landscape by Players
4.1 Global Natural Killer Cell Therapy Revenue by Players
4.1.1 Global Natural Killer Cell Therapy Revenue by Players (2019-2024)
4.1.2 Global Natural Killer Cell Therapy Revenue Market Share by Players (2019-2024)
4.1.3 Global Natural Killer Cell Therapy Players Revenue Share Top 10 and Top 5 in 2023
4.2 Global Natural Killer Cell Therapy Key Players Ranking, 2022 VS 2023 VS 2024
4.3 Global Natural Killer Cell Therapy Key Players Headquarters & Area Served
4.4 Global Natural Killer Cell Therapy Players, Product Type & Application
4.5 Global Natural Killer Cell Therapy Players Commercialization Time
4.6 Market Competitive Analysis
4.6.1 Global Natural Killer Cell Therapy Market CR5 and HHI
4.6.2 Global Top 5 and 10 Natural Killer Cell Therapy Players Market Share by Revenue in 2023
4.6.3 2023 Natural Killer Cell Therapy Tier 1, Tier 2, and Tier 3
5 Natural Killer Cell Therapy Market Size by Type
5.1 Global Natural Killer Cell Therapy Revenue by Type (2019 VS 2023 VS 2030)
5.2 Global Natural Killer Cell Therapy Revenue by Type (2019-2030)
5.3 Global Natural Killer Cell Therapy Revenue Market Share by Type (2019-2030)
6 Natural Killer Cell Therapy Market Size by Application
6.1 Global Natural Killer Cell Therapy Revenue by Application (2019 VS 2023 VS 2030)
6.2 Global Natural Killer Cell Therapy Revenue by Application (2019-2030)
6.3 Global Natural Killer Cell Therapy Revenue Market Share by Application (2019-2030)
7 Company Profiles
7.1 Nektar Therapeutics
7.1.1 Nektar Therapeutics Comapny Information
7.1.2 Nektar Therapeutics Business Overview
7.1.3 Nektar Therapeutics Natural Killer Cell Therapy Revenue and Gross Margin (2019-2024)
7.1.4 Nektar Therapeutics Natural Killer Cell Therapy Product Portfolio
7.1.5 Nektar Therapeutics Recent Developments
7.2 Innate Pharma SA
7.2.1 Innate Pharma SA Comapny Information
7.2.2 Innate Pharma SA Business Overview
7.2.3 Innate Pharma SA Natural Killer Cell Therapy Revenue and Gross Margin (2019-2024)
7.2.4 Innate Pharma SA Natural Killer Cell Therapy Product Portfolio
7.2.5 Innate Pharma SA Recent Developments
7.3 Affimed
7.3.1 Affimed Comapny Information
7.3.2 Affimed Business Overview
7.3.3 Affimed Natural Killer Cell Therapy Revenue and Gross Margin (2019-2024)
7.3.4 Affimed Natural Killer Cell Therapy Product Portfolio
7.3.5 Affimed Recent Developments
7.4 Chipscreen Biosciences
7.4.1 Chipscreen Biosciences Comapny Information
7.4.2 Chipscreen Biosciences Business Overview
7.4.3 Chipscreen Biosciences Natural Killer Cell Therapy Revenue and Gross Margin (2019-2024)
7.4.4 Chipscreen Biosciences Natural Killer Cell Therapy Product Portfolio
7.4.5 Chipscreen Biosciences Recent Developments
7.5 Glycostem Therapeutics
7.5.1 Glycostem Therapeutics Comapny Information
7.5.2 Glycostem Therapeutics Business Overview
7.5.3 Glycostem Therapeutics Natural Killer Cell Therapy Revenue and Gross Margin (2019-2024)
7.5.4 Glycostem Therapeutics Natural Killer Cell Therapy Product Portfolio
7.5.5 Glycostem Therapeutics Recent Developments
7.6 Fate Therapeutics
7.6.1 Fate Therapeutics Comapny Information
7.6.2 Fate Therapeutics Business Overview
7.6.3 Fate Therapeutics Natural Killer Cell Therapy Revenue and Gross Margin (2019-2024)
7.6.4 Fate Therapeutics Natural Killer Cell Therapy Product Portfolio
7.6.5 Fate Therapeutics Recent Developments
7.7 Dragonfly Therapeutics
7.7.1 Dragonfly Therapeutics Comapny Information
7.7.2 Dragonfly Therapeutics Business Overview
7.7.3 Dragonfly Therapeutics Natural Killer Cell Therapy Revenue and Gross Margin (2019-2024)
7.7.4 Dragonfly Therapeutics Natural Killer Cell Therapy Product Portfolio
7.7.5 Dragonfly Therapeutics Recent Developments
7.8 Kiadis Pharma
7.8.1 Kiadis Pharma Comapny Information
7.8.2 Kiadis Pharma Business Overview
7.8.3 Kiadis Pharma Natural Killer Cell Therapy Revenue and Gross Margin (2019-2024)
7.8.4 Kiadis Pharma Natural Killer Cell Therapy Product Portfolio
7.8.5 Kiadis Pharma Recent Developments
7.9 Nkarta Therapeutics
7.9.1 Nkarta Therapeutics Comapny Information
7.9.2 Nkarta Therapeutics Business Overview
7.9.3 Nkarta Therapeutics Natural Killer Cell Therapy Revenue and Gross Margin (2019-2024)
7.9.4 Nkarta Therapeutics Natural Killer Cell Therapy Product Portfolio
7.9.5 Nkarta Therapeutics Recent Developments
7.10 NantKwest
7.10.1 NantKwest Comapny Information
7.10.2 NantKwest Business Overview
7.10.3 NantKwest Natural Killer Cell Therapy Revenue and Gross Margin (2019-2024)
7.10.4 NantKwest Natural Killer Cell Therapy Product Portfolio
7.10.5 NantKwest Recent Developments
8 North America
8.1 North America Natural Killer Cell Therapy Revenue (2019-2030)
8.2 North America Natural Killer Cell Therapy Revenue by Type (2019-2030)
8.2.1 North America Natural Killer Cell Therapy Revenue by Type (2019-2024)
8.2.2 North America Natural Killer Cell Therapy Revenue by Type (2025-2030)
8.3 North America Natural Killer Cell Therapy Revenue Share by Type (2019-2030)
8.4 North America Natural Killer Cell Therapy Revenue by Application (2019-2030)
8.4.1 North America Natural Killer Cell Therapy Revenue by Application (2019-2024)
8.4.2 North America Natural Killer Cell Therapy Revenue by Application (2025-2030)
8.5 North America Natural Killer Cell Therapy Revenue Share by Application (2019-2030)
8.6 North America Natural Killer Cell Therapy Revenue by Country
8.6.1 North America Natural Killer Cell Therapy Revenue by Country (2019 VS 2023 VS 2030)
8.6.2 North America Natural Killer Cell Therapy Revenue by Country (2019-2024)
8.6.3 North America Natural Killer Cell Therapy Revenue by Country (2025-2030)
8.6.4 United States
8.6.5 Canada
9 Europe
9.1 Europe Natural Killer Cell Therapy Revenue (2019-2030)
9.2 Europe Natural Killer Cell Therapy Revenue by Type (2019-2030)
9.2.1 Europe Natural Killer Cell Therapy Revenue by Type (2019-2024)
9.2.2 Europe Natural Killer Cell Therapy Revenue by Type (2025-2030)
9.3 Europe Natural Killer Cell Therapy Revenue Share by Type (2019-2030)
9.4 Europe Natural Killer Cell Therapy Revenue by Application (2019-2030)
9.4.1 Europe Natural Killer Cell Therapy Revenue by Application (2019-2024)
9.4.2 Europe Natural Killer Cell Therapy Revenue by Application (2025-2030)
9.5 Europe Natural Killer Cell Therapy Revenue Share by Application (2019-2030)
9.6 Europe Natural Killer Cell Therapy Revenue by Country
9.6.1 Europe Natural Killer Cell Therapy Revenue by Country (2019 VS 2023 VS 2030)
9.6.2 Europe Natural Killer Cell Therapy Revenue by Country (2019-2024)
9.6.3 Europe Natural Killer Cell Therapy Revenue by Country (2025-2030)
9.6.4 Germany
9.6.5 France
9.6.6 U.K.
9.6.7 Italy
9.6.8 Russia
10 China
10.1 China Natural Killer Cell Therapy Revenue (2019-2030)
10.2 China Natural Killer Cell Therapy Revenue by Type (2019-2030)
10.2.1 China Natural Killer Cell Therapy Revenue by Type (2019-2024)
10.2.2 China Natural Killer Cell Therapy Revenue by Type (2025-2030)
10.3 China Natural Killer Cell Therapy Revenue Share by Type (2019-2030)
10.4 China Natural Killer Cell Therapy Revenue by Application (2019-2030)
10.4.1 China Natural Killer Cell Therapy Revenue by Application (2019-2024)
10.4.2 China Natural Killer Cell Therapy Revenue by Application (2025-2030)
10.5 China Natural Killer Cell Therapy Revenue Share by Application (2019-2030)
11 Asia (Excluding China)
11.1 Asia Natural Killer Cell Therapy Revenue (2019-2030)
11.2 Asia Natural Killer Cell Therapy Revenue by Type (2019-2030)
11.2.1 Asia Natural Killer Cell Therapy Revenue by Type (2019-2024)
11.2.2 Asia Natural Killer Cell Therapy Revenue by Type (2025-2030)
11.3 Asia Natural Killer Cell Therapy Revenue Share by Type (2019-2030)
11.4 Asia Natural Killer Cell Therapy Revenue by Application (2019-2030)
11.4.1 Asia Natural Killer Cell Therapy Revenue by Application (2019-2024)
11.4.2 Asia Natural Killer Cell Therapy Revenue by Application (2025-2030)
11.5 Asia Natural Killer Cell Therapy Revenue Share by Application (2019-2030)
11.6 Asia Natural Killer Cell Therapy Revenue by Country
11.6.1 Asia Natural Killer Cell Therapy Revenue by Country (2019 VS 2023 VS 2030)
11.6.2 Asia Natural Killer Cell Therapy Revenue by Country (2019-2024)
11.6.3 Asia Natural Killer Cell Therapy Revenue by Country (2025-2030)
11.6.4 Japan
11.6.5 South Korea
11.6.6 India
11.6.7 Australia
11.6.8 China Taiwan
11.6.9 Southeast Asia
12 Middle East, Africa, Latin America
12.1 MEALA Natural Killer Cell Therapy Revenue (2019-2030)
12.2 MEALA Natural Killer Cell Therapy Revenue by Type (2019-2030)
12.2.1 MEALA Natural Killer Cell Therapy Revenue by Type (2019-2024)
12.2.2 MEALA Natural Killer Cell Therapy Revenue by Type (2025-2030)
12.3 MEALA Natural Killer Cell Therapy Revenue Share by Type (2019-2030)
12.4 MEALA Natural Killer Cell Therapy Revenue by Application (2019-2030)
12.4.1 MEALA Natural Killer Cell Therapy Revenue by Application (2019-2024)
12.4.2 MEALA Natural Killer Cell Therapy Revenue by Application (2025-2030)
12.5 MEALA Natural Killer Cell Therapy Revenue Share by Application (2019-2030)
12.6 MEALA Natural Killer Cell Therapy Revenue by Country
12.6.1 MEALA Natural Killer Cell Therapy Revenue by Country (2019 VS 2023 VS 2030)
12.6.2 MEALA Natural Killer Cell Therapy Revenue by Country (2019-2024)
12.6.3 MEALA Natural Killer Cell Therapy Revenue by Country (2025-2030)
12.6.4 Mexico
12.6.5 Brazil
12.6.6 Israel
12.6.7 Argentina
12.6.8 Colombia
12.6.9 Turkey
12.6.10 Saudi Arabia
12.6.11 UAE
13 Concluding Insights
14 Appendix
14.1 Reasons for Doing This Study
14.2 Research Methodology
14.3 Research Process
14.4 Authors List of This Report
14.5 Data Source
14.5.1 Secondary Sources
14.5.2 Primary Sources
14.6 Disclaimer
List of Tables
Table 1. Global Natural Killer Cell Therapy Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Table 1. NK Cell Therapies Major Manufacturers
Table 2. NK Cell Directed Antibodies Major Manufacturers
Table 3. Global Natural Killer Cell Therapy Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Table 4. Cancer Major Manufacturers
Table 5. Gastrointestinal Diseases Major Manufacturers
Table 6. Others Major Manufacturers
Table 7. Natural Killer Cell Therapy Industry Trends
Table 8. Natural Killer Cell Therapy Industry Drivers
Table 9. Natural Killer Cell Therapy Industry Opportunities and Challenges
Table 10. Natural Killer Cell Therapy Industry Restraints
Table 11. Global Natural Killer Cell Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
Table 12. Global Natural Killer Cell Therapy Market Size by Region (2019-2024) & (US$ Million)
Table 13. Global Natural Killer Cell Therapy Market Share by Region (2019-2024)
Table 14. Global Natural Killer Cell Therapy Market Size by Region (2025-2030) & (US$ Million)
Table 15. Global Natural Killer Cell Therapy Market Share by Region (2025-2030)
Table 16. Global Natural Killer Cell Therapy Revenue by Players (US$ Million) & (2019-2024)
Table 17. Global Natural Killer Cell Therapy Revenue Market Share by Players (2019-2024)
Table 18. Global Natural Killer Cell Therapy Key Players Ranking, 2022 VS 2023 VS 2024
Table 19. Global Natural Killer Cell Therapy Key Players Headquarters & Area Served
Table 20. Global Natural Killer Cell Therapy Players, Product Type & Application
Table 21. Global Natural Killer Cell Therapy Players Commercialization Time
Table 22. Global Players Market Concentration Ratio (CR5 and HHI)
Table 23. Global Natural Killer Cell Therapy by Players Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2023)
Table 24. Global Natural Killer Cell Therapy Revenue by Type 2019 VS 2023 VS 2030 (US$ Million)
Table 25. Global Natural Killer Cell Therapy Revenue by Type (2019-2024) & (US$ Million)
Table 26. Global Natural Killer Cell Therapy Revenue by Type (2025-2030) & (US$ Million)
Table 27. Global Natural Killer Cell Therapy Revenue Market Share by Type (2019-2024) & (US$ Million)
Table 28. Global Natural Killer Cell Therapy Revenue Market Share by Type (2025-2030) & (US$ Million)
Table 29. Global Natural Killer Cell Therapy Revenue by Application 2019 VS 2023 VS 2030 (US$ Million)
Table 30. Global Natural Killer Cell Therapy Revenue by Application (2019-2024) & (US$ Million)
Table 31. Global Natural Killer Cell Therapy Revenue by Application (2025-2030) & (US$ Million)
Table 32. Global Natural Killer Cell Therapy Revenue Market Share by Application (2019-2024) & (US$ Million)
Table 33. Global Natural Killer Cell Therapy Revenue Market Share by Application (2025-2030) & (US$ Million)
Table 34. Nektar Therapeutics Company Information
Table 35. Nektar Therapeutics Business Overview
Table 36. Nektar Therapeutics Natural Killer Cell Therapy Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 37. Nektar Therapeutics Natural Killer Cell Therapy Product Portfolio
Table 38. Nektar Therapeutics Recent Development
Table 39. Innate Pharma SA Company Information
Table 40. Innate Pharma SA Business Overview
Table 41. Innate Pharma SA Natural Killer Cell Therapy Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 42. Innate Pharma SA Natural Killer Cell Therapy Product Portfolio
Table 43. Innate Pharma SA Recent Development
Table 44. Affimed Company Information
Table 45. Affimed Business Overview
Table 46. Affimed Natural Killer Cell Therapy Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 47. Affimed Natural Killer Cell Therapy Product Portfolio
Table 48. Affimed Recent Development
Table 49. Chipscreen Biosciences Company Information
Table 50. Chipscreen Biosciences Business Overview
Table 51. Chipscreen Biosciences Natural Killer Cell Therapy Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 52. Chipscreen Biosciences Natural Killer Cell Therapy Product Portfolio
Table 53. Chipscreen Biosciences Recent Development
Table 54. Glycostem Therapeutics Company Information
Table 55. Glycostem Therapeutics Business Overview
Table 56. Glycostem Therapeutics Natural Killer Cell Therapy Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 57. Glycostem Therapeutics Natural Killer Cell Therapy Product Portfolio
Table 58. Glycostem Therapeutics Recent Development
Table 59. Fate Therapeutics Company Information
Table 60. Fate Therapeutics Business Overview
Table 61. Fate Therapeutics Natural Killer Cell Therapy Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 62. Fate Therapeutics Natural Killer Cell Therapy Product Portfolio
Table 63. Fate Therapeutics Recent Development
Table 64. Dragonfly Therapeutics Company Information
Table 65. Dragonfly Therapeutics Business Overview
Table 66. Dragonfly Therapeutics Natural Killer Cell Therapy Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 67. Dragonfly Therapeutics Natural Killer Cell Therapy Product Portfolio
Table 68. Dragonfly Therapeutics Recent Development
Table 69. Kiadis Pharma Company Information
Table 70. Kiadis Pharma Business Overview
Table 71. Kiadis Pharma Natural Killer Cell Therapy Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 72. Kiadis Pharma Natural Killer Cell Therapy Product Portfolio
Table 73. Kiadis Pharma Recent Development
Table 74. Nkarta Therapeutics Company Information
Table 75. Nkarta Therapeutics Business Overview
Table 76. Nkarta Therapeutics Natural Killer Cell Therapy Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 77. Nkarta Therapeutics Natural Killer Cell Therapy Product Portfolio
Table 78. Nkarta Therapeutics Recent Development
Table 79. NantKwest Company Information
Table 80. NantKwest Business Overview
Table 81. NantKwest Natural Killer Cell Therapy Revenue and Gross Margin (US$ Million) & (2019-2024)
Table 82. NantKwest Natural Killer Cell Therapy Product Portfolio
Table 83. NantKwest Recent Development
Table 84. North America Natural Killer Cell Therapy Revenue by Type (2019-2024) & (US$ Million)
Table 85. North America Natural Killer Cell Therapy Revenue by Application (2019-2024) & (US$ Million)
Table 86. North America Natural Killer Cell Therapy Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 87. North America Natural Killer Cell Therapy Revenue by Country (2019-2024) & (US$ Million)
Table 88. North America Natural Killer Cell Therapy Revenue by Country (2025-2030) & (US$ Million)
Table 89. Europe Natural Killer Cell Therapy Revenue by Type (2019-2024) & (US$ Million)
Table 90. Europe Natural Killer Cell Therapy Revenue by Application (2019-2024) & (US$ Million)
Table 91. Europe Natural Killer Cell Therapy Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 92. Europe Natural Killer Cell Therapy Revenue by Country (2019-2024) & (US$ Million)
Table 93. Europe Natural Killer Cell Therapy Revenue by Country (2025-2030) & (US$ Million)
Table 94. China Natural Killer Cell Therapy Revenue by Type (2019-2024) & (US$ Million)
Table 95. China Natural Killer Cell Therapy Revenue by Application (2019-2024) & (US$ Million)
Table 96. Asia Natural Killer Cell Therapy Revenue by Type (2019-2024) & (US$ Million)
Table 97. Asia Natural Killer Cell Therapy Revenue by Application (2019-2024) & (US$ Million)
Table 98. Asia Natural Killer Cell Therapy Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 99. Asia Natural Killer Cell Therapy Revenue by Country (2019-2024) & (US$ Million)
Table 100. Asia Natural Killer Cell Therapy Revenue by Country (2025-2030) & (US$ Million)
Table 101. MEALA Natural Killer Cell Therapy Revenue by Type (2019-2024) & (US$ Million)
Table 102. MEALA Natural Killer Cell Therapy Revenue by Application (2019-2024) & (US$ Million)
Table 103. MEALA Natural Killer Cell Therapy Revenue by Country (2019 VS 2023 VS 2030) & (US$ Million)
Table 104. MEALA Natural Killer Cell Therapy Revenue by Country (2019-2024) & (US$ Million)
Table 105. MEALA Natural Killer Cell Therapy Revenue by Country (2025-2030) & (US$ Million)
Table 106. Research Programs/Design for This Report
Table 107. Authors List of This Report
Table 108. Secondary Sources
Table 109. Primary Sources
List of Figures
Figure 1. Natural Killer Cell Therapy Product Picture
Figure 2. Global Natural Killer Cell Therapy Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
Figure 3. Global Natural Killer Cell Therapy Market Size Share 2019 VS 2023 VS 2030
Figure 4. NK Cell Therapies Picture
Figure 5. NK Cell Directed Antibodies Picture
Figure 6. Global Natural Killer Cell Therapy Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
Figure 7. Global Natural Killer Cell Therapy Market Size Share 2019 VS 2023 VS 2030
Figure 8. Cancer Picture
Figure 9. Gastrointestinal Diseases Picture
Figure 10. Others Picture
Figure 11. Global Natural Killer Cell Therapy Market Size (US$ Million) & (2019-2030)
Figure 12. Global Natural Killer Cell Therapy Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Natural Killer Cell Therapy Market Share by Region: 2019 VS 2023 VS 2030
Figure 14. Global Natural Killer Cell Therapy Players Revenue Share Top 10 and Top 5 in 2023
Figure 15. Players Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 16. Global Natural Killer Cell Therapy Revenue by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 17. Global Natural Killer Cell Therapy Revenue Market Share 2019 VS 2023 VS 2030
Figure 18. Global Natural Killer Cell Therapy Revenue Market Share by Type (2019-2030)
Figure 19. Global Natural Killer Cell Therapy Revenue by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 20. Global Natural Killer Cell Therapy Revenue Market Share by Application (2019 VS 2023 VS 2030)
Figure 21. Global Natural Killer Cell Therapy Revenue Market Share by Application (2019-2030)
Figure 22. North America Natural Killer Cell Therapy Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 23. North America Natural Killer Cell Therapy Revenue by Type (2025-2030) & (US$ Million)
Figure 24. North America Natural Killer Cell Therapy Revenue Share by Type (2019-2030)
Figure 25. North America Natural Killer Cell Therapy Revenue by Application (2025-2030) & (US$ Million)
Figure 26. North America Natural Killer Cell Therapy Revenue Share by Application (2019-2030)
Figure 27. North America Natural Killer Cell Therapy Revenue Share by Country (2019-2030)
Figure 28. United States Natural Killer Cell Therapy Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 29. Canada Natural Killer Cell Therapy Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 30. Europe Natural Killer Cell Therapy Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 31. Europe Natural Killer Cell Therapy Revenue by Type (2025-2030) & (US$ Million)
Figure 32. Europe Natural Killer Cell Therapy Revenue Share by Type (2019-2030)
Figure 33. Europe Natural Killer Cell Therapy Revenue by Application (2025-2030) & (US$ Million)
Figure 34. Europe Natural Killer Cell Therapy Revenue Share by Application (2019-2030)
Figure 35. Europe Natural Killer Cell Therapy Revenue Share by Country (2019-2030)
Figure 36. Germany Natural Killer Cell Therapy Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 37. France Natural Killer Cell Therapy Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 38. U.K. Natural Killer Cell Therapy Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 39. Italy Natural Killer Cell Therapy Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 40. Russia Natural Killer Cell Therapy Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 41. Nordic Countries Natural Killer Cell Therapy Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 42. China Natural Killer Cell Therapy Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 43. China Natural Killer Cell Therapy Revenue by Type (2025-2030) & (US$ Million)
Figure 44. China Natural Killer Cell Therapy Revenue Share by Type (2019-2030)
Figure 45. China Natural Killer Cell Therapy Revenue by Application (2025-2030) & (US$ Million)
Figure 46. China Natural Killer Cell Therapy Revenue Share by Application (2019-2030)
Figure 47. Asia Natural Killer Cell Therapy Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 48. Asia Natural Killer Cell Therapy Revenue by Type (2025-2030) & (US$ Million)
Figure 49. Asia Natural Killer Cell Therapy Revenue Share by Type (2019-2030)
Figure 50. Asia Natural Killer Cell Therapy Revenue by Application (2025-2030) & (US$ Million)
Figure 51. Asia Natural Killer Cell Therapy Revenue Share by Application (2019-2030)
Figure 52. Asia Natural Killer Cell Therapy Revenue Share by Country (2019-2030)
Figure 53. Japan Natural Killer Cell Therapy Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 54. South Korea Natural Killer Cell Therapy Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 55. India Natural Killer Cell Therapy Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 56. Australia Natural Killer Cell Therapy Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 57. China Taiwan Natural Killer Cell Therapy Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 58. Southeast Asia Natural Killer Cell Therapy Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 59. MEALA Natural Killer Cell Therapy Revenue YoY Growth (2019-2030) & (US$ Million)
Figure 60. MEALA Natural Killer Cell Therapy Revenue by Type (2025-2030) & (US$ Million)
Figure 61. MEALA Natural Killer Cell Therapy Revenue Share by Type (2019-2030)
Figure 62. MEALA Natural Killer Cell Therapy Revenue by Application (2025-2030) & (US$ Million)
Figure 63. MEALA Natural Killer Cell Therapy Revenue Share by Application (2019-2030)
Figure 64. MEALA Natural Killer Cell Therapy Revenue Share by Country (2019-2030)
Figure 65. Mexico Natural Killer Cell Therapy Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 66. South Korea Natural Killer Cell Therapy Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 67. Brazil Natural Killer Cell Therapy Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 68. Israel Natural Killer Cell Therapy Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 69. Argentina Natural Killer Cell Therapy Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 70. Colombia Natural Killer Cell Therapy Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 71. Turkey Natural Killer Cell Therapy Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 72. Saudi Arabia Natural Killer Cell Therapy Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 73. UAE Natural Killer Cell Therapy Revenue YoY Growth (US$ Million) & (2019-2030)
Figure 74. Years Considered
Figure 75. Research Process
Figure 76. Key Executives Interviewed
